Anteris Technologies logo

AVR - Anteris Technologies Share Price

A$5.18 -0.1  -2.3%

Last Trade - 10/07/20

Sector
Healthcare
Size
Micro Cap
Market Cap £16.9m
Enterprise Value £13.9m
Revenue £9.48m
Position in Universe 1073rd / 1838
Bullish
Bearish
Unlock AVR Revenue
Momentum
Relative Strength (%)
1m -8.04%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -60.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
10.2 14.3 22.5 11.7 25.7 17.2 29.1 +10.9%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019, Anteris Technologies Ltd revenues decreased 33% to A$17.2M. Net loss decreased 76% to A$5.8M. Revenues reflect Infusion Business segment decrease of 53% to A$6.9M, ADAPT Business segment decrease of 8% to A$10.2M, Australia segment decrease of 48% to A$7.6M, United States segment decrease of 7% to A$7.1M. Lower net loss reflects ADAPT Business segment income totaling A$8M vs. loss of A$11.9M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AVR Revenue Unlock AVR Revenue

Net Income

AVR Net Income Unlock AVR Revenue

Normalised EPS

AVR Normalised EPS Unlock AVR Revenue

PE Ratio Range

AVR PE Ratio Range Unlock AVR Revenue

Dividend Yield Range

AVR Dividend Yield Range Unlock AVR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AVR EPS Forecasts Unlock AVR Revenue
Profile Summary

Anteris Technologies Ltd, formerly Admedus Ltd, is an Australia-based structural heart company. The Company provides solutions for heart valves. Its products include ADAPT and DurAVR. ADAPT its anti-calcification treatment platform technology on which its structural heart products are developed. DurAVR, built with ADAPT technology, is a durable three dimension (3D) single-piece aortic valve for the treatment of aortic stenosis. Its DurAVR Development Portfolio includes DurAVR Leaflet Repair (RP), DurAVR Transcatheter Heart Valve (THV) and DurAVR Surgical Heart Valve (SHV).

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated June 23, 1999
Public Since March 24, 2004
No. of Shareholders: n/a
No. of Employees: 1
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 5,899,428
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AVR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AVR
Upcoming Events for AVR
Frequently Asked Questions for Anteris Technologies
What is the Anteris Technologies share price?

As of 10/07/20, shares in Anteris Technologies are trading at A$5.18, giving the company a market capitalisation of £16.9m. This share price information is delayed by 15 minutes.

How has the Anteris Technologies share price performed this year?

Shares in Anteris Technologies are currently trading at A$5.18 and the price has moved by -13.67% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Anteris Technologies price has moved by -2.66% over the past year.

What are the analyst and broker recommendations for Anteris Technologies?

There are no analysts currently covering Anteris Technologies.

When will Anteris Technologies next release its financial results?

Anteris Technologies is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Anteris Technologies dividend yield?

Anteris Technologies does not currently pay a dividend.

Does Anteris Technologies pay a dividend?

Anteris Technologies does not currently pay a dividend.

When does Anteris Technologies next pay dividends?

Anteris Technologies does not currently pay a dividend.

How do I buy Anteris Technologies shares?

To buy shares in Anteris Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Anteris Technologies?

Shares in Anteris Technologies are currently trading at A$5.18, giving the company a market capitalisation of £16.9m.

Where are Anteris Technologies shares listed? Where are Anteris Technologies shares listed?

Here are the trading details for Anteris Technologies:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: AVR
What kind of share is Anteris Technologies?

Based on an overall assessment of its quality, value and momentum, Anteris Technologies is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Anteris Technologies share price forecast 2020?

We were not able to load any forecast data for Anteris Technologies.

How can I tell whether the Anteris Technologies share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Anteris Technologies. Over the past six months, the relative strength of its shares against the market has been -47.61%. At the current price of A$5.18, shares in Anteris Technologies are trading at -26.61% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Anteris Technologies PE Ratio?

We were not able to find PE ratio data for Anteris Technologies.

Who are the key directors of Anteris Technologies?

Anteris Technologies's management team is headed by:

Lynne Bradshaw - DMK
Danny Zanardo - DSL
Helen Wray - VOP
John Seaberg - NEC
Wayne Paterson - CEO
David Denis - COO
Michael Oswell - VPR
Wenyi Gu - DRC
Steve Denaro - SEC
Matthew McDonnell - CFO
Kiran Bhirangi - OTH
Yanheng Wu - NED
Who are the major shareholders of Anteris Technologies?

Here are the top five shareholders of Anteris Technologies based on the size of their shareholding:

Sio Capital Management, LLC Hedge Fund
Percentage owned: 22.18% (1.31m shares)
Constellation International Holdings Ltd. Corporation
Percentage owned: 12.35% (730k shares)
Constellation Immunotherapy Ltd. Corporation
Percentage owned: 6.27% (371k shares)
Star Bright Holdings Pty. Ltd. Corporation
Percentage owned: 2.94% (174k shares)
Chew (Patrick) Individual Investor
Percentage owned: 1.25% (73.7k shares)
Similar to AVR
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.